The clinical relevance of urinary soluble fas (sFas) for diagnosis of bilharzial bladder cancer

1. Gutierrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, Bhatia K. CpG island methylation in Schistosomaand non-Schistosoma-associated bladder cancer. Mod Pathol. 2004; 17:1268-74.10.1038/modpathol.3800177Open DOISearch in Google Scholar

2. National Cancer Institute registry. The national cancer registry newsletter, Ministry of Health and Population, Egypt. 2002.Search in Google Scholar

3. Kitamura H, Tsukamoto T. Early bladder cancer: concept, diagnosis, and management. Int J Clin Oncol. 2006; 11:28-37.10.1007/s10147-006-0552-yOpen DOISearch in Google Scholar

4. Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol. 2002; 41: 284-9.10.1016/S0302-2838(02)00006-4Open DOISearch in Google Scholar

5. Eissa S, Labib RA, Swellam M, Bassiony M, Tash FM, Al-Zayat TM. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol. 2007; 52:1388-97a.10.1016/j.eururo.2007.04.00617466450Open DOISearch in Google Scholar

6. Eissa S, Salem AM, Zohny SF, Hegazy MG. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology. Cancer Biomarkers. 2007; 3:275-80b.10.3233/CBM-2007-3601Search in Google Scholar

7. Eissa S, Swellam M, Labib RA, Mansour A, El-Malt O, Tash FM. Detection of telomerase in urine by three methods: evaluation of diagnostic accuracy of bladder cancer. J Urol. 2007; 178:1068-72c.10.1016/j.juro.2007.05.00617644139Search in Google Scholar

8. Eissa S, Zohny SF, Swellam M, Mahmoud MH, El- Zayat TM, Salem AM. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. Clin Biochem. 2008; 41:1335-41.10.1016/j.clinbiochem.2008.08.08518804101Search in Google Scholar

9. Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot. J Urol. 2009; 181:1353-60.10.1016/j.juro.2008.10.10219185322Search in Google Scholar

10. Eissa S, Shabayek MI, Ismail MF, El-Allawy RM, Hamdy MA. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer. IUBMB Life. 2010; 62:394-9a.10.1002/iub.32520408180Search in Google Scholar

11. Eissa S, Swellam M, Shehata H, El-Khouly IM, El- Zayat T, El-Ahmady O. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. J Urol. 2010; 183:493-8b.10.1016/j.juro.2009.10.02420006858Search in Google Scholar

12. Eissa S, Zohny SF, Zekri AR, El-Zayat TM, Maher AM. Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence. Med Oncol. 2010; 27:1286-91c.10.1007/s12032-009-9375-9Open DOISearch in Google Scholar

13. Eissa S, Swellam M, EL-Khouly IM, Kassim SK, Shehata H, et al. Aberrant methylation of RARb2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Cancer Epid Biomark Prev. 2011; 20:1657-64.10.1158/1055-9965.EPI-11-0237Search in Google Scholar

14. J Parker, PE Spiess. Current and emerging bladder cancer urinary biomarkers. Science World J. 2011; 11: 1103-12.10.1100/tsw.2011.104Open DOISearch in Google Scholar

15. JA Karam, Y Lotan, SF Shariat. Bladder Cancer screening and future directions in urine-based markers for bladder urothelial carcinoma. Lab Med. 2007; 38: 116-20.10.1309/FG6FGPRLDKU3FFP4Open DOISearch in Google Scholar

16. Perabo FG, Kamp S, Schmidt D, Lindner H, Steiner G, Mattes RH, et al. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation. Brit J Cancer. 2001; 84:1330-8.10.1054/bjoc.2001.1808Open DOISearch in Google Scholar

17. Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, et al. Soluble fas-a promising novel urinary marker for the detection of recurrent superficial bladder cancer. Cancer. 2006; 106:1701-7.10.1002/cncr.21795Open DOISearch in Google Scholar

18. American Joint Committee on Cancer (AJCC), Cancer staging manual. Philadelphia, Pa: Lippincott, Pa-Raven Publishers, 5th ed.; 1997.Search in Google Scholar

19. Sobin LH, Wittkind CH. UICC TNM classification of malignant tumors, 5th ed., New York: Wiley Liss; 1997. p. 187.Search in Google Scholar

20. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945; 101:519.10.1126/science.101.2629.519Open DOISearch in Google Scholar

21. Gui M, Idris MA, Shi YE, Muhling A, Ruppel A. Reactivity of Schistosoma japonicum and S. mansoni antigen preparations in indirect haemagglutination (IHA) with sera of patients with homologous and heterogonous schistosomiasis. Ann Trop Med Parasitol. 1991; 85:599-604.10.1080/00034983.1991.11812615Open DOISearch in Google Scholar

22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54.10.1016/0003-2697(76)90527-3Search in Google Scholar

23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol. 1982; 143:29-36.10.1148/radiology.143.1.70637477063747Search in Google Scholar

24. Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life. 2004; 56:557-64.10.1080/15216540400013903Open DOISearch in Google Scholar

25. Sanchez-Carbayo M, Espasa A, Chinchilla V, Herrero E, Megias J, Mira A, et al. New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer. Clin Chem. 1999; 45:1944-8.10.1093/clinchem/45.11.1944Search in Google Scholar

26. Cascino I, Fiucci G, Papoff G, Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fasmolecule are produced by alternative splicing. J Immunol. 1995; 154: 2706-13.10.4049/jimmunol.154.6.2706Search in Google Scholar

27. Liu C, Cheng J, Mountz J. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. J Biochem. 1995; 310: 957-63.10.1042/bj3100957Search in Google Scholar

28. Cheng J, Zhou T, Liu C. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994; 263:1759-62.10.1126/science.7510905Search in Google Scholar

29. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene. 1995; 10: 1157-64.Search in Google Scholar

30. Owen-Schaub LB, Angelo LS, Radinsky R, Ware CF, Gesener TG, Bartos DP. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett. 1995; 94:1-8.10.1016/0304-3835(95)03834-JOpen DOISearch in Google Scholar

31. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, et al. Melanoma cell expression of Fas (APO-1/CD95) ligand: Implication for tumor immune escape. Science. 1996; 274:1363-6.10.1126/science.274.5291.1363Search in Google Scholar

32. Mitsiades N, Poulaki V, Kotoula V, Leone A, Tsokos M. Fas ligand is present in tumors of the Ewing’s sarcoma family and is cleaved into a soluble form by a metalloproteinase. Am J Pathol. 1998; 153:1947-56.10.1016/S0002-9440(10)65708-2Search in Google Scholar

33. Boroumand-Noughabi S, Sima HR, Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Hosseinnezhad H, et al. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. BMC Cancer. 2010; 10:275-9.10.1186/1471-2407-10-275290647820534173Open DOISearch in Google Scholar

34. Konety BR. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol. 2006; 24:326-37.10.1016/j.urolonc.2005.11.02316818187Open DOISearch in Google Scholar